Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction

Sergio Leonardi, Anita Y. Chen, S. Michael Gharacholou, Tracy Y. Wang, James A de Lemos, Jorge F. Saucedo, Eric D. Peterson, Matthew T. Roe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: An early invasive management strategy is recommended for patients with non-ST-segment elevation myocardial infarction (NSTEMI) who do not have a contraindication to cardiac catheterization (CCC). However, the frequency of CCC reporting has not been delineated, and the relationship of CCC reporting to hospital-level guidelines adherence for NSTEMI has not been investigated. Methods: We used the American College of Cardiology National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines database to evaluate variations in hospital-level reporting of CCC for 111,320 patients with NSTEMI admitted to 370 hospitals with revascularization capabilities in the United States from 2007 to 2010 and how these variations were associated with guideline adherence and in-hospital mortality. Hospitals were grouped into tertiles based on rates of reported CCCs. Treatment patterns and in-hospital mortality rates were evaluated across hospital tertiles separately for patients with and without a reported CCC. Results: A total of 18,290 (16.4%) of 111,320 patients with NSTEMI had a reported CCC, but hospital-level CCC reporting varied considerably (low tertile 0%-8.2%, intermediate tertile >8.2%-18.8%, and high tertile >18.8%-75.6%). Patients with a reported CCC had more comorbidities and high-risk features compared with patients without a CCC. The use of most guideline-recommended medications and in-hospital mortality rates were similar across hospital tertiles - both for patients with and without a reported CCC. Conclusions: The reporting of CCC among patients with NSTEMI varies widely across US hospitals and does not appear to be related to guidelines adherence or in-hospital mortality rates. These findings suggest that it will be a challenge to standardize the reporting of CCC and thus use invasive management to assess the quality of NSTEMI care.

Original languageEnglish (US)
Pages (from-to)502-508
Number of pages7
JournalAmerican Heart Journal
Volume164
Issue number4
DOIs
StatePublished - Oct 2012

Fingerprint

Quality of Health Care
Cardiac Catheterization
Hospital Mortality
Guideline Adherence
Registries
Mortality
Non-ST Elevated Myocardial Infarction
Guidelines
Comorbidity
Databases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction. / Leonardi, Sergio; Chen, Anita Y.; Gharacholou, S. Michael; Wang, Tracy Y.; de Lemos, James A; Saucedo, Jorge F.; Peterson, Eric D.; Roe, Matthew T.

In: American Heart Journal, Vol. 164, No. 4, 10.2012, p. 502-508.

Research output: Contribution to journalArticle

Leonardi, Sergio ; Chen, Anita Y. ; Gharacholou, S. Michael ; Wang, Tracy Y. ; de Lemos, James A ; Saucedo, Jorge F. ; Peterson, Eric D. ; Roe, Matthew T. / Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction. In: American Heart Journal. 2012 ; Vol. 164, No. 4. pp. 502-508.
@article{2cdf574980df43eaa27a9be23b2775a4,
title = "Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction",
abstract = "Background: An early invasive management strategy is recommended for patients with non-ST-segment elevation myocardial infarction (NSTEMI) who do not have a contraindication to cardiac catheterization (CCC). However, the frequency of CCC reporting has not been delineated, and the relationship of CCC reporting to hospital-level guidelines adherence for NSTEMI has not been investigated. Methods: We used the American College of Cardiology National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines database to evaluate variations in hospital-level reporting of CCC for 111,320 patients with NSTEMI admitted to 370 hospitals with revascularization capabilities in the United States from 2007 to 2010 and how these variations were associated with guideline adherence and in-hospital mortality. Hospitals were grouped into tertiles based on rates of reported CCCs. Treatment patterns and in-hospital mortality rates were evaluated across hospital tertiles separately for patients with and without a reported CCC. Results: A total of 18,290 (16.4{\%}) of 111,320 patients with NSTEMI had a reported CCC, but hospital-level CCC reporting varied considerably (low tertile 0{\%}-8.2{\%}, intermediate tertile >8.2{\%}-18.8{\%}, and high tertile >18.8{\%}-75.6{\%}). Patients with a reported CCC had more comorbidities and high-risk features compared with patients without a CCC. The use of most guideline-recommended medications and in-hospital mortality rates were similar across hospital tertiles - both for patients with and without a reported CCC. Conclusions: The reporting of CCC among patients with NSTEMI varies widely across US hospitals and does not appear to be related to guidelines adherence or in-hospital mortality rates. These findings suggest that it will be a challenge to standardize the reporting of CCC and thus use invasive management to assess the quality of NSTEMI care.",
author = "Sergio Leonardi and Chen, {Anita Y.} and Gharacholou, {S. Michael} and Wang, {Tracy Y.} and {de Lemos}, {James A} and Saucedo, {Jorge F.} and Peterson, {Eric D.} and Roe, {Matthew T.}",
year = "2012",
month = "10",
doi = "10.1016/j.ahj.2012.07.005",
language = "English (US)",
volume = "164",
pages = "502--508",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction

AU - Leonardi, Sergio

AU - Chen, Anita Y.

AU - Gharacholou, S. Michael

AU - Wang, Tracy Y.

AU - de Lemos, James A

AU - Saucedo, Jorge F.

AU - Peterson, Eric D.

AU - Roe, Matthew T.

PY - 2012/10

Y1 - 2012/10

N2 - Background: An early invasive management strategy is recommended for patients with non-ST-segment elevation myocardial infarction (NSTEMI) who do not have a contraindication to cardiac catheterization (CCC). However, the frequency of CCC reporting has not been delineated, and the relationship of CCC reporting to hospital-level guidelines adherence for NSTEMI has not been investigated. Methods: We used the American College of Cardiology National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines database to evaluate variations in hospital-level reporting of CCC for 111,320 patients with NSTEMI admitted to 370 hospitals with revascularization capabilities in the United States from 2007 to 2010 and how these variations were associated with guideline adherence and in-hospital mortality. Hospitals were grouped into tertiles based on rates of reported CCCs. Treatment patterns and in-hospital mortality rates were evaluated across hospital tertiles separately for patients with and without a reported CCC. Results: A total of 18,290 (16.4%) of 111,320 patients with NSTEMI had a reported CCC, but hospital-level CCC reporting varied considerably (low tertile 0%-8.2%, intermediate tertile >8.2%-18.8%, and high tertile >18.8%-75.6%). Patients with a reported CCC had more comorbidities and high-risk features compared with patients without a CCC. The use of most guideline-recommended medications and in-hospital mortality rates were similar across hospital tertiles - both for patients with and without a reported CCC. Conclusions: The reporting of CCC among patients with NSTEMI varies widely across US hospitals and does not appear to be related to guidelines adherence or in-hospital mortality rates. These findings suggest that it will be a challenge to standardize the reporting of CCC and thus use invasive management to assess the quality of NSTEMI care.

AB - Background: An early invasive management strategy is recommended for patients with non-ST-segment elevation myocardial infarction (NSTEMI) who do not have a contraindication to cardiac catheterization (CCC). However, the frequency of CCC reporting has not been delineated, and the relationship of CCC reporting to hospital-level guidelines adherence for NSTEMI has not been investigated. Methods: We used the American College of Cardiology National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines database to evaluate variations in hospital-level reporting of CCC for 111,320 patients with NSTEMI admitted to 370 hospitals with revascularization capabilities in the United States from 2007 to 2010 and how these variations were associated with guideline adherence and in-hospital mortality. Hospitals were grouped into tertiles based on rates of reported CCCs. Treatment patterns and in-hospital mortality rates were evaluated across hospital tertiles separately for patients with and without a reported CCC. Results: A total of 18,290 (16.4%) of 111,320 patients with NSTEMI had a reported CCC, but hospital-level CCC reporting varied considerably (low tertile 0%-8.2%, intermediate tertile >8.2%-18.8%, and high tertile >18.8%-75.6%). Patients with a reported CCC had more comorbidities and high-risk features compared with patients without a CCC. The use of most guideline-recommended medications and in-hospital mortality rates were similar across hospital tertiles - both for patients with and without a reported CCC. Conclusions: The reporting of CCC among patients with NSTEMI varies widely across US hospitals and does not appear to be related to guidelines adherence or in-hospital mortality rates. These findings suggest that it will be a challenge to standardize the reporting of CCC and thus use invasive management to assess the quality of NSTEMI care.

UR - http://www.scopus.com/inward/record.url?scp=84867576190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867576190&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2012.07.005

DO - 10.1016/j.ahj.2012.07.005

M3 - Article

VL - 164

SP - 502

EP - 508

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4

ER -